Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective.

Srinivasan, Meenakshi; White, Annesha; Lott, Jason; Williamson, Todd; Kong, Sheldon X; Plouffe, Leo

Srinivasan, Meenakshi; White, Annesha; Lott, Jason; Williamson, Todd; Kong, Sheldon X; Plouffe, Leo.

Afiliação

Srinivasan M; University of North Texas System College of Pharmacy, Fort Worth, TX, 76107, USA.
White A; University of North Texas System College of Pharmacy, Fort Worth, TX, 76107, USA.
Lott J; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, 07981, USA.
Williamson T; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, 07981, USA.
Kong SX; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, 07981, USA.
Plouffe L; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, 07981, USA.

Gates Open Res ; 5: 171, 2021.

Article em En | MEDLINE | ID: mdl-36523752

Palavras-chave

Markov model; drug-drug interactions; economic evaluation; hormonal contraceptives; unintended pregnancies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google